Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 28, Issue 10, Pages 745-754Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/13543776.2018.1497161
Keywords
Carbonic anhydrases; metalloenzymes; bacteria; anti-infectives; biomedical application; CA inhibition; CA activation; thermostable CA
Categories
Ask authors/readers for more resources
Introduction: The hydration/dehydration of CO2 catalyzed by carbonic anhydrases (CAs, EC 4.2.1.1) is a crucial physiological reaction for the survival of all living organisms because it is connected with numerous biosynthetic and biochemical pathways requiring CO2 or HCO3-, such as respiration, photosynthesis, carboxylation reactions, pH homeostasis, secretion of electrolytes, transport of CO2, bicarbonate, etc. Areas covered: The bacterial genome encodes CAs belonging to the alpha-, beta-, and gamma-CA classes able to ensure the survival and/or satisfying the metabolic needs of the bacteria, as demonstrated by in vivo and in vitro experiments. The discovery of new anti-infectives that target new bacterial pathways, such as those involving CAs, may lead to effective therapies against diseases subject to the antibiotic resistance. This aspect is important in pharmaceutical and biomedical research but received little attention till recently. Expert opinion: An overview of the potential use of CAs in biomedical applications, as drug targets, bioindicators, and within artificial organs is presented. The discovery of thermostable bacterial CAs allowed the use of CAs in biotechnological applications, but patents related to the use of bacterial CAs in the development of pharmacological agents are scarce.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available